This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Nano Labs Presents At Institute National D'Optique Conference

Stocks in this article: CTLE

DETROIT, July 29, 2013 (GLOBE NEWSWIRE) -- Nano Labs Corp. (OTCQB:CTLE) is pleased to announce that Dr. Victor Castano, Chief Innovations Officer of Nano Labs, will be presenting "Nanotechnology and Photonics: Challenges and Opportunities in Biomedicine" today at the Institute National d'Optique conference in Montreal, Canada.

Dr. Castano will address the challenges facing biomedicine today, in terms of detection techniques, laser therapy, drug delivery and a number of other key problems requiring innovative nanotechnology solutions.

Dr. Castano will present some of the key findings and latest developments the Company has discovered holding promising value in areas including nano-diamonds, luminescent materials, and non-linear optics.

Nanotechnology and nanoparticles are playing an increasingly important role in the development of optics and medicine, including in areas of cancer treatment, drug delivery, pathogen and protein detection, fluorescent labels, DNA-related research and tissue engineering, sorting and purification of biomolecules, and NMR image enhancement.

"Photonics is one of the most exciting and active areas under research and development in the nanotechnology field today," states Dr. Castano. "Nanotechnology is one of the most promising areas to produce novel optic materials for use in biomedicine, due to the ability to tailor new material properties at the molecular level. We are looking at new nanotechnologies for everyday applications that range from the study of optics and biomedicine, to aerospace, and everything in between which makes use of optical materials. Presenting at the INO conference today in Canada, an innovation hub, helps our company to integrate and fast-track the commercialization of our technology to the healthcare industry. We are honored to be partaking in such a prestigious event."

Parties interested in learning more or to receive a copy of the presentation are invited to contact Mr. Bernardo Camacho Chavarria, President Nano Labs.

About INO

A leading technology designer and developer, INO is Canada's largest center for industrial optics and photonics expertise. It is an international leader in its field, having completed over 4,500 R&D contracts to date for Canadian companies across a wide variety of fields. INO has performed 43 technology transfers, and created 27 new high-tech startups. It boasts more than 200 employees, most of them researchers, scientists, and technicians who contribute to INO's international reputation. INO is a private, not-for-profit contract R&D company founded in 1985 by the Canadian and Quebec provincial governments. For more information please visit www.ino.ca .

About Nano Labs Nano Labs Corp. (CTLE) is a nanotechnology research and development company which began in October 2012, but is able to access resources that encompass nearly 30 years of research and development in nanotechnology as well as hundreds of peer-reviewed and published research papers and other scholarly material. Our Company's research and development team of scientists, designers, and engineers is focused on creating a portfolio of advanced products that could provide benefits to a variety of industries including: (i) consumer products, (ii) energy, (iii) materials, and (iv) healthcare. Through the use and integration of proprietary nano compounds, our goal is to evolve common products into new, revolutionary products in order to make the world a better place. Nano Labs shares are traded on the OTC Bulletin Board in the United States under the ticker CTLE. For more information, please visit www.NanoLabs.us .

The Nano Labs Corp. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=16293

Forward looking statements This press release contains forward-looking information within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1993 and Section 21E of the Securities Exchange Act of 1934 and is subject to the safe harbor created by those laws. These forward-looking statements are based upon a number of assumptions and estimates that are subject to significant uncertainties that involve known and unknown risks, many of which are beyond our control and are not guarantees of future performance. Actual outcomes and results could materially differ from what is expressed, implied, or forecasted in any such forward-looking statements and any such difference may be caused by risk factors listed from time to time in the Company's news releases and/or its filings with the OTC Bulletin Board or as a result of other factors.

CONTACT: Nano Labs Corp.
         Bernardo Camacho Chavarria
         President
         1 (888) 806-2315

Nano Labs Corp. Logo

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs